Pulmonary nodular lymphoid hyperplasia: a rare benign disease with malignant mask
Pulmonary nodular lymphoid hyperplasia: a rare benign disease with malignant mask
复制标题
DOI：
10.21037/atm.2018.12.59
复制
发表时间：
2019-02-01
影响因子：
--
通讯作者：
Hu, Jian
中科院分区：
文献类型：
--
作者：
Fang, Likui;Xu, Jinming;Hu, Jian
背景：肺结节性淋巴样增生（PNLH）是一种罕见的良性疾病，缺乏系统的临床评估。方法：回顾性分析2007年3月至2017年8月在我科确诊的PNLH患者的临床资料，探讨PNLH的临床特点及不同手术入路的安全性和有效性。收集并分析患者的详细信息，包括人口统计学特征、病史、术前检查、围手术期发现、术后情况和复发情况。我科共诊断PNLH患者67例，其中15例术前经放射学检查疑有肺癌，67例中43例行肺叶切除术，24例行肺叶切除术。与肺叶切除术相比，肺叶下切除术在手术时间上有明显优势（P
Background: Pulmonary nodular lymphoid hyperplasia (PNLH) is a rare benign disease lacking systematically clinical assessment. This study aims to explore the clinical features of PNLH and evaluate the safety and efficacy of different surgical approaches for PNLH.Methods: Patients with confirmed PNLH in our department between March 2007 and August 2017 were retrospectively reviewed. The detail information of patients, including demographic characteristics, medical history, preoperative investigations, perioperative findings, postoperative conditions, and recurrence status, was collected and analyzed.Results: A total of 67 patients with PNLH were diagnosed in our department, and 15 of them were suspected to have lung cancer by radiological examination before the surgery 43 of 67 patients underwent sublobar resection and 24 patients underwent lobectomy. Compared with the lobectomy, sublobar resection showed more significant advantages in operation time (P